Interview with Nihal Aygun, CEO, Corena Turkey
Mrs Aygun, could you please introduce yourself to our readers and give us an overview of CORENA? I have an educational background in chemistry and a professional experience in several…
Address: ‘Eski Büyükdere Cad. Dilaver Sok. NO:4 34418
Oto Sanayi 4 Levent / İstanbul
,Turkey
Tel: +90 212 316 78 00
Web: http://www.aliraif.com.tr/
Ali Raif was founded under the name of Ali Raif ve Şeriki (Ali Raif and Associate) in 1928. Then company was reorganized in order to trade in pharmaceuticals industry by Muzaffer Turhan in 1963. Since 1983, the company has had operations under the name of Ali Raif Pharmaceutical Inc. Co.
Ali Raif was marketing pharmaceuticals as a licensee of multinational companies in the early years of its foundation. Then the company became one of the leading companies of the Turkish Pharmaceutical Industry starting to import finished pharmaceuticals and to produce and market generic pharmaceuticals.
After Ali Raif commenced generic pharmaceuticals licensing, producing and marketing, export opportunities started to arise in parallel to them. Export activities started with Azerbaijan and Georgia has enlarged with EU countries in 2003. Since 2005 they have speeded up greatly.
The countries that have been export are England, Portugal, Hungary, Azerbaijan, Georgia, The Philippines, Bulgaria, Spain, Algeria, and Poland.
Ali Raif has nearly 150 pharmaceuticals with their forms in therapeutic fields such as cardiovascular, diabetics, gastrointestinal, analgesic, anti-inflammatory, anti-flu, antihistaminic, central nervous system.
Headquarters and production facilities are located in İkitelli, İstanbul, has totally 10 regional offices in Turkey.
Mrs Aygun, could you please introduce yourself to our readers and give us an overview of CORENA? I have an educational background in chemistry and a professional experience in several…
You are among the youngest GM’s of the top 200 companies in Turkey. What factors would you attribute to the rapid advancement of your career? I would say that there…
Astellas has been present in the German market for almost two decades through Yamanouchi and Fujisawa. But since 2005 it gained a new identity thanks to the merger of the…
Mr Yusuf, Pharmaceutical Executive’s readers are keen to discover, through our reports, prominent industry personalities, and they like to hear their stories. Having been instrumental in the formation of the…
IEIS is an association with dual responsibilities. Promotion of generic usage in turkey and ensuring the sustained development of a local manufacturing industry. Before we look into these two aspects,…
Even though you have delivered strong results in most of the markets you have been appointed, this is your first assignment as the head of a subsidiary. For a man…
We are here with a very young company, created in 2009, so only three years old. As you mentioned before the interview, you first started to work in the medical…
Mr Sözeri, Pharmaceutical Executive’s readers are keen to discover, through our reports, prominent industry personalities, and they like to hear their stories. You have an outstanding career, having worked for…
Before we start with the interview I noticed that previously you were in charge of other regions aside from turkey. Is that still the case? If not why did IMS…
Could you introduce the organisation and its objectives to our readers? The International Investors Association of Turkey (YASED) is a non-governmental organization whose members are international companies operating in Turkey.…
Turkey remains a country between two worlds. Not only is it straddled between Asia and Europe, it also boasts a very strong and modern “western” industry and infrastructure together with…
See our Cookie Privacy Policy Here
